Dexamethasone for Pediatric Rhabdomyolysis
Dexamethasone Use in Pediatric Rhabdomyolysis Patients in Addition to Standard Protocols
Recruiting
Phase 1
Interventional Study
Rhabdomyolysis
At a Glance
- Age
- 6 Months – 25
- Sex
- Any
- Trial phase
- Phase 1
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 50 (estimated)
- Sponsor
- Children's National Research Institute · Other
Who this trial is looking for
This trial is looking for children and teenagers with rhabdomyolysis. Participants will receive dexamethasone along with standard treatments to see if it helps improve their pain and hospital stay.
Are You a Good Fit for This Trial?
You may be able to join if
- I have been diagnosed with rhabdomyolysis.
- I am 12 years old or older.
- I can understand and sign a consent form.
You may not be able to join if
- I am already taking steroids.
- I cannot follow study instructions.
- I have an uncontrolled illness or mental health issue.
- I am pregnant.
- I am younger than 40 weeks old.
- I am allergic to fluconazole, clotrimazole, or nystatin.
- I cannot take medications by mouth.
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
There is a significant unmet need for optimized treatment in rhabdomyolysis. There are few prospective interventional studies on treatment for rhabdomyolysis, a condition which affects diverse and underrepresented populations at a higher rate. While steroids are often used off-label, a systematic study has not yet been initiated, and steroids have not been yet considered in as a consideration to s…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria
1. Diagnosis of rhabdomyolysis defined as creatine kinase\> 5000 with trauma excluded
2. Ability of parents/patients to understand and the willingness to sign a written informed consent document.
3. Patients ages 12 and older will sign written assent
Exclusion Criteria:
* Alrea…
Contacts